Skip to main content
All lobbying filings

Walgreen Company

Walgreen Company filed a Q4 report for Walgreen Company on January 22, 2026.

Lobbying for Walgreen Company

As filed: WALGREEN COMPANY for WALGREEN COMPANY.

All filings by Walgreen Company · Everything Walgreen Company has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 22, 2026
Expenses
$450,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3
Pharmacy

- H.R.3164: Ensuring Community Access to Pharmacist Services Act: Issues related to access to pharmacist services - H.R. 4317: The PBM Reform Act: Issues related to pharmacy benefit managers - H.R. 2484: Seniors Critical Access to Medications Act; issues related to pharmacist services - Issues related to 340B - Issues related to vaccine access

Consumer Issues/Safety/Products

- H.R. 2853/S.1404: The Combatting Organized Retail Crime Act: Issues related to preventing organized retail crime

Taxation/Internal Revenue Code

- Work Opportunity Tax Credit

 Bills named in this filing 5
  • H.R. 3164
    Ensuring Community Access to Pharmacist Services Act
  • H.R. 4317
    PBM Reform Act of 2025
  • H.R. 2484
    Seniors’ Access to Critical Medications Act of 2025
  • H.R. 2853
    Combating Organized Retail Crime Act of 2025
  • S. 1404
    Combating Organized Retail Crime Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem